Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lifestream Technologies

This article was originally published in The Tan Sheet

Executive Summary

A smart card-enabled Cholesterol Monitor will be available to consumers by year-end pending FDA approval, the Post Falls, Idaho-based company says. The device uses one drop of blood to determine cholesterol levels in three minutes; the results are then encrypted and downloaded on the included Privalink Microsoft Smart Card for Windows, allowing them to be sent to doctors or pharmacists via the Internet; the data also can be delivered in person. Other software records cholesterol levels for later review. Print advertising and an infomercial will promote the product to consumers and professionals, who must cooperate in establishing an information system to receive and store the data. The monitor will retail for $129.95, with packets of six test kits selling for $19.95

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091406

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel